Browsing by Subject "Progesterone"

Sort by: Order: Results:

Now showing items 1-5 of 5
  • Montserrat Rivera del Alamo, Maria; Reilas, Tiina; Galvao, Antonio; Yeste, Marc; Katila, Terttu (2018)
    Treatment with intrauterine devices (IUD) prolongs luteal phases in mares, but the mechanism for this has not been fully elucidated. The aims of the present study were to examine how IUDs affect the uterus to induce longer luteal phases, particularly the role of cyclooxygenase-2 (COX-2) in the maintenance of the corpus luteum (CL). Twenty-seven reproductively normal mares were included: 12 were inseminated (AI), and 15 were fitted with IUDs. Blood samples for progesterone were obtained on Days 0, 3, 5, 7, 9, 11, 13, 14, and 15 (relative to day of ovulation). The groups were further divided into non-pregnant (AI-N, n = 4), pregnant (AI-P, n = 8), normal (IUD-N, n = 8) and prolonged luteal phase (IUD-P, n = 7) based on ultrasonic examinations and serum progesterone concentrations on Days 14 and 15. Blood sampling to quantify the PGF(2 alpha) metabolite (PGFM) was performed through a catheter hourly from 15:00 to 20:00 h on Day 14, and from 6:00 until 13:00 h on Day 15. On Day 15, a low-volume uterine lavage followed by an endometrial biopsy was performed. Estradiol concentration in the Day 15 serum and lavage fluid was determined, while the abundance of COX-2 was evaluated in the biopsy specimens using western blotting (WB) and irnmunohistochemistry (IHC). All pregnant mares were negative for COX-2 in IHC samples and 5 of 8 were negative in WB samples while all mares of the IUD-N group were positive for COX-2. Of the seven mares in the IUD-P group, five and four were negative for COX-2 with the IHC and WB samples, respectively. The results from this study indicate that IUDs, when effective, suppress COX-2, leading to the inhibition of PGF2 alpha release and maintenance of CL.
  • Tamminen, Tuire; Sahlin, Lena; Masironi-Malm, B.; Dahlbom, Merja; Katila, Terttu; Taponen, Juhani; Vapaavuori, Outi (2019)
    This study aimed to examine the etiology of canine dystocia by measuring the relative expression of oxytocin receptor (OXTR) mRNA and the concentration of serum progesterone, plasma PGF(2 alpha) metabolite (PGFM), and blood ionized calcium (iCa) near term and in dystocia. Altogether 58 bitches were included in this study, 41 of which underwent cesarean section (CS). The four CS groups were based on history: complete uterine inertia (CUI; n = 7), partial uterine inertia (PUI; n = 13), obstructive dystocia (OD; n = 10), and elective cesarean section (ECS; n = 11). An additional group of medically treated dystocia without CS (MD; n = 8) and a control group (C; n = 9) with normal parturition (without CS and medical treatment) were also formed. Blood samples were taken prior to CS or medical treatment. Progesterone concentrations were highest in the ECS and a significant difference (p <0.05) was observed between the ECS and the OD and between the ECS and the combined dystocia (CUI, PUI, OD, MD) groups (COMB). Highest concentrations of PGFM was observed in the C, the difference being significant (p <0.05) between the C and the ECS and between the C and the COMB group. The progesterone:PGFM ratio was significantly (p <0.05) higher in the ECS than in the C and the COMB group. No significant difference (p> 0.05) was observed in iCa concentrations between the groups. Relative OXTR mRNA expression was evaluated with real-time PCR from full-thickness uterine samples taken from the incision site during CS. The expression was highest in the ECS and the difference in expression was significant (p <0.05) between the ECS and the OD and between ECS and the combined dystocia (CUI, PUI, OD) groups (COMB2). The study supports previous reports of decreasing progesterone and increasing PGFM during prepartum luteolysis. Upregulation of OXTR occurs near term. In obstructive dystocia, a prolonged influence of oxytocin and uterine exhaustion may lead to downregulation of OXTR. Complete primary uterine inertia may have a different etiology as no clear decrease in OXTR was observed in CUI as in OD. It remains unclear if parturition ceases because of uterine inertia or if uterine inertia occurs because of ceased parturition and desensitization of receptors. (C) 2019 Elsevier Inc. All rights reserved.
  • Heikinheimo, Oskari; Apter, Dan (2018)
  • El Fellah, Samira; Duporte, Geoffroy; Siren, Heli (2017)
    Steroid hormones, botrydial, and inorganic ions were studied from cold and hot tap water samples with capillary electrophoresis techniques using UV detection. Identification of the steroids and botrydial was made with ultra-high -performance liquid chromatography (UHPLC) coupled to electrospray ionization orbitrap high-resolution mass spectrometry. Solid phase extraction with nonpolar and ion-exchange sorbents was needed to enrich the compounds for CE and UHPLC studies. The steroids identified from the drinking water samples were estradiol glucoside, androstenedione, testosterone, and progesterone. However, only progesterone could be quantified in both cold and hot tap water samples from Helsinki households. Its concentration varied from 0.031 ng/L to 0.135 ng/L and from 0.054 ng/L to 0.191 ng/L, respectively. Chloride and nitrate amounts were 25 mg/L. Calcium, potassium, magnesium, and sodium were 20, 1, 1, and 17 mg/L at the highest, respectively. Copper, iron, sulphate, and ammonium were below the methods concentration limits. Botrydial from Botrytis cinerea mould was identified in all drinking waters. In both cold and hot tap waters its concentration was 861-3900% higher than in a drilled well water that was also used as the household tap water. The mould was also confirmed by identification of its metabolite abscisic acid. (C) 2017 Elsevier B.V. All rights reserved.
  • Schütt, Marcel; The Duy Nguyen; Kalff-Suske, Martha; Wagner, Uwe; Macharey, Georg; Ziller, Volker (2021)
    Objective: Progesterone application for luteal phase support is a well-established concept in in vitro fertilization (IVF) treatment. Water-soluble subcutaneous progesterone injections have shown pregnancy rates equivalent to those observed in patients receiving vaginal administration in randomized controlled trials. Our study aimed to investigate whether the results from those pivotal trials could be reproduced in daily clinical practice in an unselected patient population. Methods: In this retrospective cohort study in non-standardized daily clinical practice, we compared 273 IVF cycles from 195 women undergoing IVF at our center for luteal phase support with vaginal administration of 200 mg of micronized progesterone three times daily or subcutaneous injection of 25 mg of progesterone per day. Results: Various patient characteristics including age, weight, height, number of oocytes, and body mass index were similar between both groups. We observed no significant differences in the clinical pregnancy rate (CPR) per treatment cycle between the subcutaneous (39.9%) and vaginal group (36.5%) (p=0.630). Covariate analysis showed significant correlations of the number of transferred embryos and the total dosage of stimulation medication with the CPR. However, after adjustment of the CPR for these covariates using a regression model, no significant difference was observed between the two groups (odds ratio, 0.956; 95% confidence interval, 0.512-1.786; p=0.888). Conclusion: In agreement with randomized controlled trials in study populations with strict selection criteria, our study determined that subcutaneous progesterone was equally effective as vaginally applied progesterone in daily clinical practice in an unselected patient population.